seroprevalence


Also found in: Wikipedia.

ser·o·prev·a·lence

(ser-ō-prev'ă-lents),
Prevalence of a marker as measured by results of serologic testing.
[sero- + prevalence]

seroprevalence

[-prev′ələns]
the overall occurrence of a disease within a defined population at one time, as measured by blood tests. An example is human immunodeficiency virus seroprevalence.

seroprevalence

Immunology The proportion of a population that is seropositive–ie, has been exposed to a particular pathogen or immunogen; the seropositivity of a population is calculated as the number of individuals who produce a particular antibody divided by the total population

ser·o·prev·a·lence

(ser-ō-prev'ă-lens)
Prevalence of a marker as measured by results of serologic testing.
References in periodicals archive ?
We undertook this study to determine the seroprevalence of JCV in humans and white-tailed deer in this province.
In the areas in the Philippines where Dengvaxia was introduced (mainly through school programs), the seroprevalence (or the rate of incidence of dengue infection) was estimated to be at least 85 percent," it said.
gondii infection, but despite this high worldwide prevalence, there are large variations in the seroprevalence from country to country (from 0 to 80%), within the same country, and even across different communities.
However, when compared with some of the individual studies, our results indicated a rise in the seroprevalence of HIV(63-65).
It is in this purpose that a sero-survey was lead in 2015 where 1286 animals were sampled (1085 sheep and 201 goats), 315 were positive with a global seroprevalence of (24.
In addition, seroprevalence rates of HSV-1 and VZV were higher in hemodialysis patients; however, these differences did not reach statistical significance (85.
The percentage of IgG seroprevalence was higher in women who ever got pregnant as compared to those who were never pregnant (13% vs 5%).
2 Congenital CMV in low-and middle-income countries and is mostly due to secondary maternal infections; whereas, in western settings with moderate levels of seroprevalence (70% in USA) 25% of congenital CMV are due to primary and 75% due to secondary maternal infections, in countries where seroprevalence is relatively low (50% European countries), primary and secondary infections contribute equally for occurrence of congenital CMV infection.
The objectives were to determine the leptospirosis seroprevalence and to identify the predominant infecting serovars among cattle farmers.
Hence, a study was undertaken to estimate the seroprevalence of HCV in general population, with special reference to haemodialysis patients.